title: Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
abstract: Chlamydia trachomatis is the most common cause of sexually transmitted bacterial infection globally. These infections translate to a significant public health burden, particularly women's healthcare costs due to serious disease sequelae such as pelvic inflammatory disease (PID), tubal factor infertility, chronic pelvic pain, and ectopic pregnancy. There is no evidence that natural immunity can provide complete, long-term protection necessary to prevent chronic pathology, making human vaccine development critical. Vaccine design will require careful consideration of protective versus pathological host-response mechanisms in concert with elucidation of optimal antigens and adjuvants. Evidence suggests that a Th1 response, facilitated by IFN-γ-producing CD4 T cells, will be instrumental in generating long-term, sterilizing immunity. Although the role of antibodies is not completely understood, they have exhibited a protective effect by enhancing chlamydial clearance. Future work will require investigation of broadly neutralizing antibodies and antibody-augmented cellular immunity to successfully design a vaccine that potently elicits both arms of the immune response. Sterilizing immunity is the ultimate goal. However, vaccine-induced partial immunity that prevents upper genital tract infection and inflammation would be cost-effective compared to current screening and treatment strategies. In this chapter, we examine evidence from animal and human studies demonstrating protective adaptive immune responses to Chlamydia and discuss future challenges and prospects for vaccine development.
authors.affiliation: Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: Taylor B
authors.initials: TB
authors.lastname: Poston
authors.affiliation: Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA. lad@email.unc.edu.
authors.forename: Toni
authors.initials: T
authors.lastname: Darville
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D002690:Chlamydia Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology
chemical_list: D057134:Antibodies, Neutralizing; D001428:Bacterial Vaccines